Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Turner, N. C."'
Autor:
Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., André F; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France., Barrios CH; Oncology Research Center, Grupo Oncoclínicas, Porto Alegre, Brazil., Cortés J; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain; Scientific Department, Medica Scientia Innovation Research, Valencia, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., de Azambuja E; Medical Oncology Department, Institute Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., DeMichele A; Hematology/Oncology Department, Hospital of the University of Pennsylvania, Philadelphia, USA., Dent R; Department of Medical Oncology, National Cancer Centre Singapore, Singapore., Fenlon D; College of Human and Health Sciences, Swansea University-Singleton Park Campus, Swansea, UK., Gligorov J; Départment d' Oncologie Médicale, Institut Universitaire de Cancérologie AP-HP, Sorbonne Université, Hôpital Tenon, Paris, France., Hurvitz SA; Department of Medicine/Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, USA; Jonsson Comprehensive Cancer Center, Los Angeles, USA., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Krug D; Department of Radiation Oncology, University Hospital Schleswig-Holstein-Campus Kiel, Kiely, Germany., Kunz WG; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia., Penault-Llorca F; Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR INSERM-UCA, Clermont Ferrand, France., Ricke J; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Robson M; Medicine Department, Memorial Sloan Kettering Cancer Center, New York, USA., Rugo HS; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA., Saura C; Breast Cancer Program, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Schmid P; Centre of Experimental Cancer Medicine, Cancer Research UK Barts Centre, Barts and The London School of Medicine and Dentistry, London, UK., Singer CF; Center for Breast Health and Department of Obstetrics & Gynecology, Medical University of Vienna, Vienna, Austria., Spanic T; Europa Donna Slovenia, Slovenia, USA., Tolaney SM; Dana-Farber Cancer Institute, Boston, USA., Turner NC; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy., Loibl S; GBG Forschungs GmbH, Neu-Isenburg, Germany., Paluch-Shimon S; Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel., Harbeck N; Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1475-1495. Date of Electronic Publication: 2021 Oct 19.
Autor:
Turner NC; Breast Unit, The Royal Marsden NHS Foundation Trust, London, UK; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. Electronic address: Nick.Turner@icr.ac.uk., Alarcón E; Clinical Oncology Department, British American Hospital, Lima, Peru., Armstrong AC; Department of Medical Oncology, Christie Hospital NHS Foundation Trust and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Philco M; Peruvian Institute of Oncology Radiotherapy, Lima, Peru., López Chuken YA; University Hospital, Monterrey, Mexico., Sablin MP; Department of Drug Development and Innovation (D3i), Curie Institute, Paris, France., Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Gómez Villanueva A; Clinical Oncology Unit, Private Hemato-Oncology Center, Toluca, Mexico., Pérez-Fidalgo JA; Medical Oncology Unit, INCLIVA Biomedical Research Institute, University Clinical Hospital of Valencia, Valencia; CIBERONC, Health Institute Carlos III, Madrid, Spain., Cheung SYA; IMED Biotech Unit, AstraZeneca, Cambridge., Corcoran C; Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge., Cullberg M; IMED Biotech Unit, AstraZeneca, Cambridge., Davies BR; IMED Biotech Unit, AstraZeneca, Cambridge., de Bruin EC; IMED Biotech Unit, AstraZeneca, Cambridge., Foxley A; IMED Biotech Unit, AstraZeneca, Cambridge., Lindemann JPO; IMED Biotech Unit, AstraZeneca, Cambridge., Maudsley R; IMED Biotech Unit, AstraZeneca, Cambridge., Moschetta M; IMED Biotech Unit, AstraZeneca, Cambridge., Outhwaite E; Anchora Consultancy Ltd, Devon, UK., Pass M; IMED Biotech Unit, AstraZeneca, Cambridge., Rugman P; IMED Biotech Unit, AstraZeneca, Cambridge., Schiavon G; IMED Biotech Unit, AstraZeneca, Cambridge., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 May 01; Vol. 30 (5), pp. 774-780.
Autor:
Condorelli R; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France; Institute of Oncology and Breast Unit of Southern Switzerland, Bellinzona, Switzerland., Mosele F; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France. Electronic address: Mariafernanda.MOSELE@gustaveroussy.fr., Verret B; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France., Bachelot T; Department of Medical Oncology, Cancer Research Center of Lyon Inserm, Lyon, France., Bedard PL; Division of Medical Oncology & Hematolog, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Canada., Cortes J; Ramon y Cajal University Hospital, Madrid & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Hyman DM; Memorial Sloan Kettering Cancer Center, New York., Juric D; Massachusetts General Hospital (MGH), Boston., Krop I; Dana-Farber Cancer Institute, Boston, USA., Bieche I; Department of Genetics, Curie Institute, Paris, France., Saura C; Department of Medical Oncolog, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Sotiriou C; J.C. Heuson Breast Cancer Translational Research Laborator, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium., Cardoso F; Breast Uni, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Loibl S; German Breast Group, Neu-Isenburg, Germany., Andre F; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France., Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, UK.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Mar 01; Vol. 30 (3), pp. 365-373.
Autor:
Hurvitz SA; University of California, Los Angeles, 10945 Le Conte Avenue PVUB 3360, Los Angeles, CA, 90095, USA. Electronic address: SHurvitz@mednet.ucla.edu., Quek RGW; Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: Ruben.Quek@pfizer.com., Turner NC; The Royal Marsden Hospital-The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, SW3 6JJ, UK. Electronic address: Nicholas.Turner@icr.ac.uk., Telli ML; Stanford University School of Medicine, 900 Blake Wilbur Drive, 1st Floor, Palo Alto, CA, 94304, USA. Electronic address: mtelli@stanford.edu., Rugo HS; University of California San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA, 94115, USA. Electronic address: Hope.Rugo@ucsf.edu., Mailliez A; Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France. Electronic address: a-mailliez@o-lambret.fr., Ettl J; Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany. Electronic address: johannes.ettl@tum.de., Grischke E; Universitäts-Frauenklinik Calwerstr. 7, 72076, Tübingen, Germany; Eberhard Karls University, Geschwister-Scholl-Platz, 72074, Tübingen, Germany. Electronic address: eva-maria.grischke@med.uni-tuebingen.de., Mina LA; Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr, Gilbert, AZ, 85234, USA. Electronic address: Lida.Mina@bannerhealth.com., Balmaña J; Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, CELLEX CENTER, C/ Natzaret, 115-117, 08035, Barcelona, Spain. Electronic address: jbalmana@vhio.net., Fasching PA; University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsstraße 21-23, 91054 Erlangen Erlangen, Germany. Electronic address: Peter.Fasching@uk-erlangen.de., Bhattacharyya H; Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: Helen.Bhattacharyya@pfizer.com., Hannah AL; Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: Alison.Hannah@pfizer.com., Robson ME; Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. Electronic address: robsonm@mskcc.org., Wardley AM; The NIHR Manchester Clinical Research Facility at The Christie & Division of Cancer Sciences University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: Andrew.Wardley@christie.nhs.uk.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Nov; Vol. 104, pp. 160-168. Date of Electronic Publication: 2018 Oct 22.
Autor:
Turner NC; Toby Robins Breast Cancer Research Centre, Institute of Cancer Research and Royal Marsden Hospital, London, UK. Electronic address: nick.turner@icr.ac.uk., Finn RS; Department of Medicine, David Geffen School of Medicine, Los Angeles, USA., Martin M; Department of Medicine, Hospital Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., DeMichele A; Department of Medicine, University of Pennsylvania, Philadelphia, USA., Ettl J; Klinik und Poliklinik fuer Frauenheilkunde Klinikum Rechts der Isar, Technische Universitaet Muenchen, Munich, Germany., Diéras V; Department of Clinical Research, Institut Curie, Paris, France., Moulder S; Department of Breast Medical Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, USA., Lipatov O; State Budget Medical Institution Republican Clinical Oncology Dispensary, Ufa, Russia., Colleoni M; European Institute of Oncology, Milan, Italy., Cristofanilli M; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago., Lu DR; Pfizer Inc, La Jolla, USA., Mori A; Pfizer S.r.l, Milan, Italy., Giorgetti C; Pfizer S.r.l, Milan, Italy., Iyer S; Pfizer Inc, New York, USA., Bartlett CH; Pfizer Inc, New York, USA., Gelmon KA; Department of Medical Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, Canada.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Mar 01; Vol. 29 (3), pp. 669-680.
Autor:
Garcia-Murillas I; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Sharpe R; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Pearson A; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Campbell J; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Natrajan R; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Ashworth A; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Turner NC; 1] The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK [2] Breast Unit, Royal Marsden Hospital, London, UK.
Publikováno v:
Oncogene [Oncogene] 2014 May 08; Vol. 33 (19), pp. 2478-86. Date of Electronic Publication: 2013 Jun 10.
Autor:
Turner NC; Chester Beatty Laboratories, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK., Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, Savage K, Gillett CE, Schmitt FC, Ashworth A, Tutt AN
Publikováno v:
Oncogene [Oncogene] 2007 Mar 29; Vol. 26 (14), pp. 2126-32. Date of Electronic Publication: 2006 Oct 02.
Autor:
Turner NC; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London, UK. nicholas.turner@icr.ac.uk, Reis-Filho JS
Publikováno v:
Oncogene [Oncogene] 2006 Sep 25; Vol. 25 (43), pp. 5846-53.